Tuberculosis & HIV: Treatment
- Researchers Discuss Advances in Tuberculosis Treatment (March 11, 2013)
From HIVandHepatitis.com
- TB: CDC Encourages Docs to Check for Antibiotic Resistance (December 5, 2012)
In CATIE News, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- An Overview of Rifampin (Rifadin, Rimactane) (October 2, 2012)
From AIDSinfo
- Efavirenz Interaction Studies With TB Compounds Bedaquiline and Delamanid (September/October 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Experimental Nitroimidazole TBA-354 Shows Promise Against Tuberculosis in Early Studies (September 11, 2012)
From HIVandHepatitis.com
- Need for Expanded Access to Two Promising MDR TB Drugs (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- HHS Guidelines Panels Issue Statement on Treating Latent Tuberculosis Infection in People Infected With HIV Receiving Antiretroviral Therapy (December 20, 2011)
Short-course (3-month) therapy with weekly isoniazid-rifapentine is NOT RECOMMENDED for HIV-infected patients receiving antiretroviral therapy.
From AIDSinfo
- Earlier Versus Later Start of Antiretroviral Therapy in HIV-Infected Adults With Tuberculosis (October 31, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- AstraZeneca Joins Rival to Develop New TB Treatment (March 15, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The First New Tuberculosis Drug in Decades: Promise and Challenges (Winter 2011)
To read PDF, click here.
In TAGline, from Treatment Action Group
On TheBodyPRO.com
- Inflammatory Disease Drugs Could Hold TB Treatment Key (August 20, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- TB and HIV Management in High Prevalence Settings: From Coordination to Integration (July 21, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
- Combination ART, TB Treatment Slash Co-Infected Patient Mortality Rates, Study Finds (February 26, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Two New Classes of TB Drugs -- the First in 40 Years -- Advance Through Phase II Studies (Winter 2010)
After 40 years of scientific stagnation, it is beginning to be an exciting time in tuberculosis treatment research.
To read PDF, click here.
In TAGline, from Treatment Action Group
- IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials (July 24, 2009)
A brief recap of selected mainstream media coverage of research presented at IAS 2009.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- d4T Toxicity Risk 7-Fold Higher When Started With TB Treatment (June 18, 2009)
From aidsmap.com
- Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission (March 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- South Africa Tries Treating TB Patients at Home (March 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Tuberculosis Treatments and Drugs (January 28, 2009)
From Mayo Clinic
- FDA Issues "Black Box" Warning for Cipro, Similar Drugs (July 9, 2008)
From Project Inform
- An Overview of Isoniazid (INH, Nydrazid) (April 30, 2007)
From AIDSinfo
|
Advertisement
|
Email
Glossary
